| Date Filed | Type | Description |
| 06/12/2023 |
4
| Lee June (Director) has filed a Form 4 on Tenaya Therapeutics, Inc.|
Txns:
| Granted 29,532 options to buy
@ $7.12, valued at
$210.3k
|
|
| 05/02/2023 |
4
| Lee June (Director) has filed a Form 4 on Eledon Pharmaceuticals, Inc.|
Txns:
| Granted 150,437 options to buy
@ $2.3, valued at
$346k
|
|
| 02/24/2023 |
4
| Lee June (Director) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Disposed/sold 47,954 options to buy
@ $16, valued at
$767.3k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Lee June (Director) has filed a Form 4 on Eledon Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $3.97, valued at
$79.4k
|
|
| 01/10/2022 |
4
| Lee June (Director) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Granted 47,954 options to buy
@ $16, valued at
$767.3k
|
|
| 01/06/2022 |
3
| Lee June (Director) has filed a Form 3 on CinCor Pharma, Inc. |
| 11/22/2021 |
4
| Lee June (Director) has filed a Form 4 on Tenaya Therapeutics, Inc.|
Txns:
| Granted 18,937 options to buy
@ $21.65, valued at
$410k
|
|
| 11/22/2021 |
3
| Lee June (Director) has filed a Form 3 on Tenaya Therapeutics, Inc. |
| 12/14/2020 |
3
| Lee June (Director) has filed a Form 3 on Novus Therapeutics, Inc. |
| 10/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/24/2019 |
4
| Lee June (EVP, Chief Development Officer) has filed a Form 4 on MyoKardia Inc|
Txns:
| Sold 3,929 shares
@ $58.3313, valued at
$229.2k
Sold 4,161 shares
@ $58.9736, valued at
$245.4k
Sold 800 shares
@ $59.95, valued at
$48k
Sold 4,161 shares
@ $61.089, valued at
$254.2k
Exercised 12,625 options to buy
@ $11.95, valued at
$150.9k
|
|
| 09/20/2019 |
4
| Lee June (EVP, Chief Development Officer) has filed a Form 4 on MyoKardia Inc|
Txns:
| Sold 5,435 shares
@ $57.0844, valued at
$310.3k
Exercised 5,435 options to buy
@ $11.95, valued at
$64.9k
|
|
| 08/12/2019 |
4
| Lee June (EVP, Chief Development Officer) has filed a Form 4 on MyoKardia Inc|
Txns:
| Sold 4,565 shares
@ $57.003, valued at
$260.2k
Exercised 4,565 options to buy
@ $11.95, valued at
$54.6k
|
|
| 06/03/2019 |
4
| Lee June (EVP, Chief Development Officer) has filed a Form 4 on MyoKardia Inc|
Txns:
| Granted 401 shares
@ $40.783, valued at
$16.4k
|
|
| 03/18/2019 |
4
| Lee June (See Remarks) has filed a Form 4 on MyoKardia Inc|
Txns:
| Exercised 1,758 options to buy
@ $11.95, valued at
$21k
|
|
| 02/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2019 |
4
| Lee June (See Remarks) has filed a Form 4 on MyoKardia Inc|
Txns:
| Paid exercise price by delivering 1,100 shares
@ $44.0613, valued at
$48.5k
|
|
| 01/03/2019 |
4
| Lee June (See Remarks) has filed a Form 4 on MyoKardia Inc|
Txns:
| Exercised 2,750 restricted stock units
@ $0 |
|
| 12/06/2018 |
4
| Lee June (See Remarks) has filed a Form 4 on MyoKardia Inc|
Txns:
| Granted 344 shares
@ $42.16, valued at
$14.5k
Sold 2,800 shares
@ $60.077, valued at
$168.2k
Sold 1,200 shares
@ $61.0711, valued at
$73.3k
Sold 800 shares
@ $62.2586, valued at
$49.8k
Sold 200 shares
@ $63.76, valued at
$12.8k
Exercised 5,000 options to buy
@ $11.95, valued at
$59.8k
|
|
| 09/24/2018 |
4
| Lee June (See Remarks) has filed a Form 4 on MyoKardia Inc|
Txns:
| Sold 4,092 shares
@ $62.9739, valued at
$257.7k
Sold 908 shares
@ $63.8359, valued at
$58k
Exercised 5,000 options to buy
@ $11.95, valued at
$59.8k
|
|
| 06/29/2018 |
4
| Lee June (See Remarks) has filed a Form 4 on MyoKardia Inc|
Txns:
| Granted 6,250 options to buy
@ $11.95, valued at
$74.7k
|
|
| 06/01/2018 |
4
| Lee June (See Remarks) has filed a Form 4 on MyoKardia Inc|
Txns:
| Granted 426 shares
@ $33.15, valued at
$14.1k
|
|
| 01/18/2018 |
4
| Lee June (See Remarks) has filed a Form 4 on MyoKardia Inc|
Txns:
| Granted 66,400 options to buy
@ $52, valued at
$3.5M
Granted 11,000 restricted stock units
@ $0 |
|
| 02/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/01/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |